The 6 analysts offering 12-month price forecasts for Decibel Therapeutics Inc have a median target of 13.00, with a high estimate of 23.00 and a low estimate of 7.00. The median estimate represents a +295.14% increase from the last price of 3.29.
The current consensus among 6 polled investment analysts is to Buy stock in Decibel Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.40
Reporting Date Mar 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.